Videos |View More
Video
A Comprehensive Overview of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Metastatic Melanoma
Tuesday, April 9, 2024 5:30 - 6:30 PM EDT - On the heels of the FDA’s recent approval of AMTAGVI (lifileucel) for unrescectable or metastatic melanoma, join Roswell Park subject matter experts for a comprehensive provider education event.
Video
Benefits of Combining Beta-Blocker and Checkpoint Inhibitor
The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.
Video
Welcome to Roswell Park | Shalana O'Brien, MD
Shalana O'Brien, MD, is a highly skilled surgical oncologist treating patients with melanoma/skin cancers, endocrine disorders and cancers, and specializing in heated chemotherapy (HIPEC) to treat advanced cancers that have spread within the abdomen.
News |View More
News
Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park
Congressman Kennedy announced $7,731,872 in funding for the Roswell Park Comprehensive Cancer Center to renovate its newly integrated biobank, the Roswell Park Biorepository, made possible through the Office of the Director of the National ...
News
Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
Region’s only Comprehensive Cancer Center earns maximum rating, marking five decades of consecutive NCI support.
News
Clinical Trial Evaluates Smaller Surgical Margins for Stage 2 Melanoma Patients
Although most primary cutaneous melanomas are treated with surgical excision alone, current international guidelines vary on the optimal size for the surgical margins, which can range from 1 to 3 cm. based on Breslow thickness.
News
Using CBL0137 To Treat Patients With Advanced Extremity Melanoma or Sarcoma
A central question in oncology is how to offer efficacious treatments while minimizing toxicity. This is especially true when treating advanced sarcoma and melanoma of the extremity.
News
New findings could lead to better tools for the identification of at-risk individuals, earlier cancer prevention.
News
JAMA Oncology provides new insights that survival benefits are held regardless of BRAF mutation status or earlier targeted therapy.
This site is intended for healthcare professionals
Download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.
BROADCASTMED